Cage Pharma

Baltimore, United States

Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.

$137K raised

May 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cage Pharma raised?

Cage Pharma has raised $137K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.

Who are Cage Pharma's investors?

Cage Pharma's investors include Catalio Capital Management.

Where is Cage Pharma headquartered?

Cage Pharma is headquartered in Baltimore, United States.

What does Cage Pharma do?

Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.

What stage is Cage Pharma at?

Cage Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 31, 2024.

MLA

"Cage Pharma — Funding & Investors." VCBacked, May 31, 2024, https://www.vcbacked.co/company/cage-pharma. Accessed July 4, 2026.

APA

VCBacked. (2024). Cage Pharma — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/cage-pharma

Wikipedia (cite web)

{{cite web |title=Cage Pharma — Funding & Investors |url=https://www.vcbacked.co/company/cage-pharma |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 31, 2024.